Allergy Research Group was the first to introduce melatonin into the U.S. market.
Slow Motion Melatonin is a specially prepared low dose melatonin which is stabilized in a lipid matrix. The patent-pending lipid matrix tablet system protects the melatonin from harsh gastric juices, and is designed to allow absorption via the lymph. Preparations that do not use the lipid matrix system must first go through the portal vein system. The ‘slow motion’-like property is a byproduct of the micronized lipid matrix system.
The body synchronizes secretion of endogenous melatonin with the duration of the biological night. Usual melatonin preparations are characterized by fast systemic release and metabolism, due to the short half-life of the melatonin molecule. This typically results in a spike into supra-physiologic levels 1 to 2 hours after ingestion, followed by a gradual return to normal levels.
Poorly prepared modified release preparations can keep melatonin in the system for many hours after wakeup, resulting in carry-over “hangover” effects. Such unnatural presence of high melatonin levels during the day can lead to phase-delay in the circadian clock and potentially make sleep problems even worse.
• Stabilized in a special lipid matrix for protection and optimized absorption
• Low dose more closely mimics physiologic secretion
• Reduced likelihood of spikes and morning “hangover” effects